|
Volumn 7, Issue 2, 2001, Pages 167-173
|
Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum
a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETIC ACID;
ACYL CARRIER PROTEIN;
ANTIMALARIAL AGENT;
CARBON 14;
CERULENIN;
CHLOROQUINE;
ENOYL ACYL CARRIER PROTEIN REDUCTASE;
MALONYL COENZYME A;
NICOTINAMIDE ADENINE DINUCLEOTIDE;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;
TRICLOSAN;
UNCLASSIFIED DRUG;
AMINO ACID SEQUENCE;
ANIMAL CELL;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG MECHANISM;
DRUG POTENCY;
DRUG PROTEIN BINDING;
ENZYME INHIBITION;
FATTY ACID SYNTHESIS;
GROWTH INHIBITION;
LIFE CYCLE;
MALARIA;
MOUSE;
NONHUMAN;
PLASMODIUM BERGHEI;
PLASMODIUM FALCIPARUM;
PRIORITY JOURNAL;
AMINO ACID SEQUENCE;
ANIMALS;
ANTIMALARIALS;
DISEASE MODELS, ANIMAL;
ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH);
FATTY ACIDS;
MALARIA;
MICE;
MICE, INBRED BALB C;
MOLECULAR SEQUENCE DATA;
NAD;
OXIDOREDUCTASES;
PLASMODIUM BERGHEI;
PLASMODIUM FALCIPARUM;
TRICLOSAN;
ANIMALIA;
PLASMODIUM BERGHEI;
PLASMODIUM FALCIPARUM;
PROTOZOA;
|
EID: 0035126479
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/84612 Document Type: Article |
Times cited : (408)
|
References (40)
|